Pulse Biosciences is an innovative bioelectric medicine company focused on advancing health technology to enhance patient quality of life. Utilizing its proprietary CellFX® nsPFA™ technology, the company delivers precise nanosecond pulses of electrical energy to non-thermally ablate cells, preserving surrounding noncellular tissue. Pulse Biosciences is dedicated to developing its technology for surgical treatments, particularly in areas like atrial fibrillation, aiming to make a significant positive impact on healthcare. The company fosters a culture of creativity and collaboration, prioritizing the hiring of top talent to drive its mission of improving patient outcomes through high-quality, reliable medical products and services.